Se­qens ma­jor­i­ty own­er look­ing to sell API mak­er amid record-high run in health­care val­u­a­tions: re­port

Three years af­ter it re­brand­ed from No­va­cap, Se­qens, a French phar­ma­ceu­ti­cal man­u­fac­tur­er and in­gre­di­ent sup­pli­er is re­port­ed­ly be­ing prepped for sale.

The sale comes as …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER